Literature DB >> 12504221

Slow progression of periampullary neoplasia in familial adenomatous polyposis.

Kouros L Moozar1, Lisa Madlensky, Terri Berk, Steven Gallinger.   

Abstract

Variable endoscopic surveillance protocols and treatment strategies have been proposed for periampullary neoplasia in familial adenomatous polyposis (FAP), primarily because of the lack of long-term, prospective natural history data. A total of 115 patients with FAP were followed prospectively for 10 years with periodic side-viewing upper gastrointestinal endoscopy by a single surgeon. The appearance of the duodenum was classified as stages 1 to 5. Statistical analysis included one-way analysis of variance for age comparisons between stage groupings and Kaplan-Meier analysis for the lifetime risks of having a particular stage of duodenal polyposis. Eighty-seven patients had multiple endoscopies over an average of 6.6 years. Thirty-three subjects had a change in stage, within an average time of 3.9 years at an average age of 41 years. The risk of having stage 3 or 4 duodenal neoplasia increased exponentially after the age of 40. The degree of dysplasia did not correlate with stage at initial classification. Progression of neoplasia in the duodenum of patients with FAP is slow. The severity of duodenal polyposis increases with age and is not influenced by the initial stage. The average time for progression of adenoma to carcinoma is likely long.

Entities:  

Mesh:

Year:  2002        PMID: 12504221     DOI: 10.1016/s1091-255x(02)00062-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  30 in total

1.  Natural history of ampullary adenoma in familial adenomatous polyposis: reconfirmation of benign nature during extended surveillance.

Authors:  T Matsumoto; M Iida; S Nakamura; K Hizawa; T Yao; M Tsuneyoshi; M Fujishima
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

Review 2.  Screening modalities in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer.

Authors:  A D Spigelman
Journal:  Gastrointest Endosc Clin N Am       Date:  1997-01

3.  Causes of death in familial adenomatous polyposis.

Authors:  T S Galle; K Juel; S Bülow
Journal:  Scand J Gastroenterol       Date:  1999-08       Impact factor: 2.423

Review 4.  Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas.

Authors:  G Griffioen; P J Bus; H F Vasen; H W Verspaget; C B Lamers
Journal:  Scand J Gastroenterol Suppl       Date:  1998

5.  Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study.

Authors:  C J Groves; B P Saunders; A D Spigelman; R K S Phillips
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.

Authors:  R K S Phillips; M H Wallace; P M Lynch; E Hawk; G B Gordon; B P Saunders; N Wakabayashi; Y Shen; S Zimmerman; L Godio; M Rodrigues-Bigas; L-K Su; J Sherman; G Kelloff; B Levin; G Steinbach
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  Role of upper gastrointestinal surveillance in patients with familial adenomatous polyposis.

Authors:  T Sawada; T Muto
Journal:  Gastrointest Endosc Clin N Am       Date:  1997-01

Review 8.  Management of advanced duodenal polyposis in familial adenomatous polyposis.

Authors:  C Soravia; T Berk; G Haber; Z Cohen; S Gallinger
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

9.  Upper intestinal surveillance in familial adenomatous polyposis.

Authors:  H S Debinski; A D Spigelman; A Hatfield; C B Williams; R K Phillips
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

10.  Upper gastrointestinal cancer in familial adenomatous polyposis.

Authors:  D G Jagelman; J J DeCosse; H J Bussey
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

View more
  17 in total

Review 1.  Prevention and management of duodenal polyps in familial adenomatous polyposis.

Authors:  L A A Brosens; J J Keller; G J A Offerhaus; M Goggins; F M Giardiello
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients.

Authors:  Kazuya Inoki; Takeshi Nakajima; Satoru Nonaka; Seiichiro Abe; Haruhisa Suzuki; Shigetaka Yoshinaga; Ichiro Oda; Masayoshi Yamada; Mizuki Takatsu; Hiroshi Yoshida; Hirokazu Taniguchi; Shigeki Sekine; Yuichiro Ohe; Yutaka Saito
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 3.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version).

Authors:  Hideyuki Ishida; Tatsuro Yamaguchi; Kohji Tanakaya; Kiwamu Akagi; Yasuhiro Inoue; Kensuke Kumamoto; Hideki Shimodaira; Shigeki Sekine; Toshiaki Tanaka; Akiko Chino; Naohiro Tomita; Takeshi Nakajima; Hirotoshi Hasegawa; Takao Hinoi; Akira Hirasawa; Yasuyuki Miyakura; Yoshie Murakami; Kei Muro; Yoichi Ajioka; Yojiro Hashiguchi; Yoshinori Ito; Yutaka Saito; Tetsuya Hamaguchi; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Hiroshi Kawano; Yusuke Kinugasa; Norihiro Kokudo; Keiko Murofushi; Takako Nakajima; Shiro Oka; Yoshiharu Sakai; Akihiko Tsuji; Keisuke Uehara; Hideki Ueno; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Michio Itabashi; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Yasuhiro Shimada; Keiichi Takahashi; Shinji Tanaka; Osamu Tsuruta; Toshiharu Yamaguchi; Kenichi Sugihara; Toshiaki Watanabe
Journal:  J Anus Rectum Colon       Date:  2018-05-25

Review 4.  Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis.

Authors:  Michelle C Gallagher; Robin K S Phillips; Steffen Bulow
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

5.  Extracolonic manifestations of hereditary colorectal cancer syndromes.

Authors:  Daniel A Anaya; George J Chang; Miguel A Rodriguez-Bigas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

Review 6.  Review of the investigation and surgical management of resectable ampullary adenocarcinoma.

Authors:  James Askew; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

7.  Laparoscopic colectomy for cancer.

Authors:  David W Larson; Heidi Nelson
Journal:  J Gastrointest Surg       Date:  2004 Jul-Aug       Impact factor: 3.452

8.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

9.  Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis.

Authors:  Wesley H Greenblatt; Chin Hur; Amy B Knudsen; John A Evans; Daniel C Chung; G Scott Gazelle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-29       Impact factor: 4.254

Review 10.  Evaluation and management of periampullary tumors.

Authors:  William A Ross; Mike M Bismar
Journal:  Curr Gastroenterol Rep       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.